Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Parallel Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension

NCT03860220 is registered in ClinicalTrials.gov with Hyo-Soo Kim as lead sponsor.

NCT NCT03860220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03860220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Parallel Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension
Lead sponsor
Hyo-Soo Kim
Phase
Phase 4
Overall status
Completed
Start date
April 25, 2019
Completion date
September 7, 2023
Enrollment
252 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, hypertension